AR072781A1 - Composiciones que comprenden cdb-4124 y metodos de contracepcion masculina - Google Patents
Composiciones que comprenden cdb-4124 y metodos de contracepcion masculinaInfo
- Publication number
- AR072781A1 AR072781A1 ARP090101511A ARP090101511A AR072781A1 AR 072781 A1 AR072781 A1 AR 072781A1 AR P090101511 A ARP090101511 A AR P090101511A AR P090101511 A ARP090101511 A AR P090101511A AR 072781 A1 AR072781 A1 AR 072781A1
- Authority
- AR
- Argentina
- Prior art keywords
- man
- methyl
- compound
- cdb
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4844408P | 2008-04-28 | 2008-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR072781A1 true AR072781A1 (es) | 2010-09-22 |
Family
ID=40756947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090101511A AR072781A1 (es) | 2008-04-28 | 2009-04-28 | Composiciones que comprenden cdb-4124 y metodos de contracepcion masculina |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR072781A1 (zh) |
CL (1) | CL2009001009A1 (zh) |
TW (1) | TW200950788A (zh) |
WO (1) | WO2009134713A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107072948A (zh) * | 2014-09-30 | 2017-08-18 | 田纳西大学研究基金会 | 用于长效药物传递的原位凝胶剂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8173626B2 (en) * | 2006-03-08 | 2012-05-08 | Danco Laboratories Llc | Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders |
-
2009
- 2009-04-09 TW TW098111782A patent/TW200950788A/zh unknown
- 2009-04-27 WO PCT/US2009/041795 patent/WO2009134713A1/en active Application Filing
- 2009-04-28 AR ARP090101511A patent/AR072781A1/es unknown
- 2009-04-28 CL CL2009001009A patent/CL2009001009A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2009001009A1 (es) | 2009-06-19 |
TW200950788A (en) | 2009-12-16 |
WO2009134713A1 (en) | 2009-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR117670A2 (es) | Modulador del receptor de andrógeno y sus usos | |
WO2013016697A3 (en) | 17-hydroxyprogesterone ester-containing oral compositions and related methods | |
ECSP034654A (es) | Productos de hormona esteroide y metodos para preparar los mismos | |
BRPI0512993A (pt) | uso de um antagonista de pr, kit farmaceuticamente últil, e, método de contracepção em uma fêmea em idade de parto | |
PE20060275A1 (es) | Composicion farmaceutica que contiene progestina y estrogeno para el tratamiento de trastorno disforico premenstrual | |
BRPI0512991A (pt) | uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto | |
NZ602698A (en) | Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis | |
AR070379A1 (es) | Sistema de administracion de drogas con efecto estabilizante | |
BRPI0516243C1 (pt) | uso de um precursor de esteróide sexual selecionado do grupo que consiste em dehidroepiandrosterona, sulfato de dehidroepiandrosterona, androst-5-eno-3b,17b-diol e 4-androsten-3,17-diona, uso do referido precursor em 5 associação com um modulador de receptor de estrogênio seletivo para proteção uterina e da glândula mamária contra câncer, composição farmacêutica e kit | |
BR122017008910A8 (pt) | Composições formuladas para injeção intramuscular e usos de um éster de testosterona | |
AR061289A1 (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
CL2011000044A1 (es) | Uso de una composicion farmaceutica oral que comprende al menos un antagonista opioide seleccionado de naloxona, naltrexona, nalbufino o sus sales, adicionalmente puede comprender al menos un agonista opioide, tal como oxicodona, morfina u otros, para el tratamiento de la retencion urinaria. | |
NZ581081A (en) | Synthetic deoxycholic acid (dca) or an ester, hydroxamale, or hydroxyamide thereof | |
PE20070188A1 (es) | Formulaciones de estrogenos conjugados y bazedoxifeno | |
PE20100034A1 (es) | Dispositivo para mejorar un metodo de voladura | |
BRPI0912112B8 (pt) | composição farmacêutica compreendendo composto tendo atividade antagonística em receptor de adenosina a2a útil em suprimir tolerância analgésica | |
BR112018010107A2 (pt) | composição farmacêutica para o tratamento ou prevenção de nash | |
BR112012015016A8 (pt) | Formulação farmacêutica, forma de dosagem farmacêutica entérica e uso de uma formulação | |
AR072781A1 (es) | Composiciones que comprenden cdb-4124 y metodos de contracepcion masculina | |
AU2003251636A1 (en) | COMPOSITION CONTAINING AN ANDROGENOUS 11Beta-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION | |
PE20071315A1 (es) | Formulaciones de compuestos derivados de fenilo y procesos de preparacion para tabletas que contienen dichos compuestos | |
PE20160655A1 (es) | Profarmacos de formacion de compuestos | |
AR083820A1 (es) | Sujetador para montar un dispositivo de suministro de fluido | |
BR112013002280A2 (pt) | composições farmacêuticas orais de liberação controlada compreendendo blonanseina | |
PE20190707A1 (es) | Formulaciones de buprenorfina de liberacion sostenida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |